NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health Advocate and Former Major League Baseball Player Drew Robinson
May 03, 2022 12:59 ET
|
Neuronetics
A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
NeuroStar® Advanced Therapy Launches New “Tap Into a New Possibility” Campaign for Depression Awareness
March 03, 2022 10:00 ET
|
Neuronetics
MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide
March 01, 2022 08:31 ET
|
Neuronetics
MALVERN, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
January 10, 2022 08:31 ET
|
Neuronetics
MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health
December 20, 2021 08:31 ET
|
Neuronetics
MALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference
December 06, 2021 08:31 ET
|
Neuronetics
MALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics and River Region Psychiatry Announce Exclusive Partnership
November 08, 2021 10:00 ET
|
Neuronetics
Partnership Will Bring Non-drug NeuroStar® Advanced Therapy For Mental Health To Thousands of Patients Across the Southeast MALVERN, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
October 26, 2021 08:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
October 19, 2021 08:31 ET
|
Neuronetics
System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology...
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
October 04, 2021 08:40 ET
|
Neuronetics
MALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...